Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001959173-25-002152
Filing Date
2025-03-18
Accepted
2025-03-18 16:26:54
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2989
  Complete submission text file 0001959173-25-002152.txt   4402
Mailing Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618
Business Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618 (949) 409-9820
Tarsus Pharmaceuticals, Inc. (Subject) CIK: 0001819790 (see all company filings)

EIN.: 814717861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39614 | Film No.: 25748787
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 15440 LAGUNA CANYON ROAD, SUITE 160 IRVINE CA 92618
Business Address
Wahl Bryan (Reporting) CIK: 0001841401 (see all company filings)

Type: 144